EFTA Document EFTA01371259

EFTA Document EFTA01357168

From: Jesse-J Cruz Sent: Thursday, May 03, 2018 3:05 PM To: AMLUK Reviews <amluk.reviews a7db.com>• amluk compliance <amluk.compliance€clb.com> Cc: Zack Bunimovich >; Kareen Johnson Subject: Escalation: ONB-1135648 / LKYCGB-160049 / Southern Financial LLC (I] Classification: For internal use only Hi All, We are performing a principal product extension for Southern Financial, LLC for GED, Convertible Bonds, and Global Credit Derivatives in DBAG. D8car triggered a high risk rating. Attach

Bibliographic list with no actionable investigative content

The passage consists solely of academic citations and a document identifier, offering no names, transactions, dates, or allegations linking influential actors to any controversy. It provides no leads List of scientific publications on topics such as chaos theory, physiology, and psychology Document identifier HOUSE_OVERSIGHT_013792 with no contextual information

EFTA Document EFTA01357152

UK AFC are kindly in receipt of the KCP GM policy dated June 2017 (duly noted that this is currently under review), this document has proved useful in giving context to the UK GM product nexus with solely a US booking. Due to the local UK time, I will be discussing KCP Extensions with my management on Monday as to best understand and process such requests in the future. I truly appreciate the time and knowledge that has been shared and look forward to our conversations next week as to supp

EFTA Document EFTA01357151

a. KCP clients had migrated from dbCLIENT to dbCAR, potentially the migration did not complete correctly (this will continue to be investigated SEPERATELY to this Extension request) b. At the very first adoption of the client/extension to UK GM products, this was not correctly booked within our internal systems iv. Fixes to the dbCAR profile were discussed between Global CDS teams, of which the latter was chosen due to time constraints and the impact upon our first line colleagues; a.

Trump meets with top health‑care executives at Mar‑a‑Lago amid ACA repeal push

The passage lists specific senior executives from major medical institutions and two billionaire CEOs meeting the president‑elect, suggesting possible influence on health‑care policy. It provides name Meeting took place on Dec. 28, 2016 at Mar‑a‑Lago, Palm Beach. Attendees included CEOs of Mayo Clinic, Johns Hopkins Medicine, Partners HealthCare, Cleveland Clini No donors to Trump’s campaign among

EFTA01368143